Mount Sinai Beth Israel

Mount Sinai Researchers Develop Treatment That Turns Tumors Into Cancer Vaccine Factories

Retrieved on: 
Monday, April 8, 2019

The second stimulant activates the dendritic cells, which then instruct T cells, the immune system's soldiers, to kill cancer cells and spare non-cancer cells.

Key Points: 
  • The second stimulant activates the dendritic cells, which then instruct T cells, the immune system's soldiers, to kill cancer cells and spare non-cancer cells.
  • "The in situ vaccine approach has broad implications for multiple types of cancer," said lead author Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
  • Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.
  • For more information, visit http://www.mountsinai.org/ , or find Mount Sinai on Facebook, Twitter and YouTube.

January Is Cervical Cancer Awareness Month, Tips From Mount Sinai

Retrieved on: 
Friday, January 4, 2019

Radiation: Uses high-energy X-rays or other types of radiation to kill cancer cells or keep them from growing.

Key Points: 
  • Radiation: Uses high-energy X-rays or other types of radiation to kill cancer cells or keep them from growing.
  • The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat.
  • Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.
  • For more information, visit http://www.mountsinai.org/ , or find Mount Sinai on Facebook, Twitter and YouTube.

Mount Sinai Researchers Use "Blacklist" Computing Concept as Novel Method to Streamline Genetic Analysis

Retrieved on: 
Monday, December 24, 2018

Using blacklisting as a filter to single out genetic variations in patient genomes and exomes that do not cause illness, researchers have successfully streamlined the identification of genetic drivers of disease.

Key Points: 
  • Using blacklisting as a filter to single out genetic variations in patient genomes and exomes that do not cause illness, researchers have successfully streamlined the identification of genetic drivers of disease.
  • "Using the blacklist, researchers will now be able to remove genetic 'noise' and focus on true disease-causing mutations."
  • Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.
  • For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Mount Sinai Health System and Arena Address AI-Driven Hiring for Healthcare at Leading Industry Conference

Retrieved on: 
Monday, July 16, 2018

"Mount Sinai Health System has a long tradition of leveraging advances in science and technology to provide the best care for our community," said Jane Maksoud.

Key Points: 
  • "Mount Sinai Health System has a long tradition of leveraging advances in science and technology to provide the best care for our community," said Jane Maksoud.
  • "When we first started working with Mount Sinai Health System, we guaranteed we would reduce their employee turnover by 10%," said Myra Norton.
  • The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region.
  • The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and 50th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally.